BRIEF published on 01/19/2026 at 10:05, 8 months 8 days ago Medios AG Enters Medicinal Cannabis Market European Market Medios AG Pharmaceutical Distribution Medicinal Cannabis Bedrocan Partnership
PRESS RELEASE published on 01/19/2026 at 10:00, 8 months 8 days ago Medios AG enters market for medicinal cannabis Medios AG expands into medicinal cannabis market with exclusive distribution rights for Bedrocan products in Europe, strengthening expertise in oncology and neurology Pharmaceuticals Oncology Medios AG Medicinal Cannabis Bedrocan
BRIEF published on 11/11/2025 at 07:29, 10 months 17 days ago Medios AG annonce une forte croissance de ses bénéfices début 2025 EBITDA Performance Financière Medios AG Croissance Des Revenus Médicaments
BRIEF published on 11/11/2025 at 07:29, 10 months 17 days ago Medios AG Reports Robust Earnings Growth in Early 2025 EBITDA Revenue Growth Financial Performance Pharmaceuticals Medios AG
PRESS RELEASE published on 11/11/2025 at 07:24, 10 months 17 days ago Medios AG achieves strong growth in earnings and profit margin in the first nine months of 2025 Medios AG achieves 9.2% revenue growth and 26.1% increase in EBITDA pre1 in the first nine months of 2025. New CEO appointed. Outlook confirmed. Details in press release EBITDA Revenue Growth CEO Appointment Medios AG 2025 Outlook
BRIEF published on 11/03/2025 at 10:02, 10 months 24 days ago Thomas Meier Appointed CEO of Medios AG Growth Strategy CEO Appointment Medios AG Specialty Pharma Thomas Meier
BRIEF published on 11/03/2025 at 10:02, 10 months 24 days ago Thomas Meier nommé PDG de Medios AG Stratégie De Croissance Medios AG Nomination Du PDG Pharmacie Spécialisée Thomas Meier
PRESS RELEASE published on 11/03/2025 at 09:57, 10 months 24 days ago Thomas Meier becomes new CEO of Medios AG Thomas Meier appointed as new CEO of Medios AG effective February 1, 2026, succeeding Matthias Gaertner. Meier's past roles include CEO of Bachem Holding AG. Medios AG aims for further growth under his leadership CEO Appointment Medios AG Specialty Pharma Thomas Meier Bachem Holding AG
BRIEF published on 10/24/2025 at 11:09, 11 months 3 days ago Medios AG : Réattribution des actions Bencis Medios AG Pharmaceutique Spécialisée Réallocation Des Actions Bencis Capital Partners Groupe Janus Henderson
BRIEF published on 10/24/2025 at 11:09, 11 months 3 days ago Medios AG: Reallocation of Bencis Shares Medios AG Specialty Pharma Share Reallocation Bencis Capital Partners Janus Henderson Group
Published on 09/26/2026 at 01:00, 2 days 6 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 9 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 14 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 16 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/28/2026 at 07:13, 17 minutes ago Cameo Resources: High-Tech Gold Hunt in the Shadow of AngloGold!
Published on 09/28/2026 at 07:05, 25 minutes ago Arcadis deepens Autodesk collaboration to accelerate AI and data-led delivery for clients
Published on 09/28/2026 at 07:00, 30 minutes ago DKSH and Grünenthal Announce New Partnership Agreement to Accelerate Access to Innovative Pain Management Solutions Across Eight Markets in Asia-Pacific
Published on 09/28/2026 at 06:45, 45 minutes ago HBM Healthcare Investments Increases Its Stake in Portfolio Company ADARx Pharmaceuticals Through IPO
Published on 09/28/2026 at 06:20, 1 hour 10 minutes ago Aurra Markets Crowned 'Best Emerging Broker' at Forex Expo Dubai 2026
Published on 09/25/2026 at 17:45, 2 days 13 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 13 hours ago Availability of the 2026 half-year financial report
